186 related articles for article (PubMed ID: 37718438)
1. A collision tumor of nasopharyngeal carcinoma and primary mantle cell lymphoma in the nasopharynx: a case report and review of the literature.
Jiang M; Yuan XP; Zhang H; Li CQ; Mao YL; Chen WL
BMC Oral Health; 2023 Sep; 23(1):672. PubMed ID: 37718438
[TBL] [Abstract][Full Text] [Related]
2. Unusual coexistence of extramedullary plasmacytoma and nasopharyngeal carcinoma in nasopharynx.
Du RC; Li HN; Huang W; Tian XY; Li Z
Diagn Pathol; 2015 Sep; 10():170. PubMed ID: 26376733
[TBL] [Abstract][Full Text] [Related]
3. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
4. Case report: metastases from thyroid and nasopharyngeal carcinomas in the same lymph node following chemotherapy for mantle cell lymphoma.
Wang Z; Luo D; Xiao H; Joshua Liao D
Head Neck Pathol; 2015 Mar; 9(1):123-6. PubMed ID: 24519375
[TBL] [Abstract][Full Text] [Related]
5. Correlation of PET-CT, MRI and histopathology findings in the follow-up of patients with nasopharyngeal cancer.
Ak S; Kiliç C; Özlügedik S
Braz J Otorhinolaryngol; 2021; 87(6):643-648. PubMed ID: 31982379
[TBL] [Abstract][Full Text] [Related]
6. Collision Kidney Tumor Consisting of Clear Cell Renal Cell Carcinoma and Primary Renal Mantle Cell Lymphoma: A Case Report.
Yang H; Wang P
Arch Esp Urol; 2023 Oct; 76(8):627-632. PubMed ID: 37960962
[TBL] [Abstract][Full Text] [Related]
7. Can Arterial Spin Labeling Perfusion Imaging be Used to Differentiate Nasopharyngeal Carcinoma From Nasopharyngeal Lymphoma?
Sun Z; Hu S; Ge Y; Jin L; Huang J; Dou W
J Magn Reson Imaging; 2021 Apr; 53(4):1140-1148. PubMed ID: 33225524
[TBL] [Abstract][Full Text] [Related]
8. Post-radiation CT changes and recurrent nasopharyngeal carcinoma.
Luo DH; Zhou CW; Li EN; Wen BX
Chin Med J (Engl); 2008 May; 121(10):916-22. PubMed ID: 18706206
[TBL] [Abstract][Full Text] [Related]
9. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
[TBL] [Abstract][Full Text] [Related]
11. Expression of glucose transporter-1, hypoxia-inducible factor-1α, phosphatidylinositol 3-kinase and protein kinase B (Akt) in relation to [(18)F]fluorodeoxyglucose uptake in nasopharyngeal diffuse large B-cell lymphoma: a case report and literature review.
Fang J; Luo XM; Yao HT; Zhou SH; Ruan LX; Yan SX
J Int Med Res; 2010; 38(6):2160-8. PubMed ID: 21227022
[TBL] [Abstract][Full Text] [Related]
12. [Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Chen L; Zhang N; Wang Y; Xian W; Hu W; Wei G
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):213-5. PubMed ID: 25975792
[TBL] [Abstract][Full Text] [Related]
13. Image-based diagnosis of residual or recurrent nasopharyngeal carcinoma may be a phantom tumor phenomenon.
Lee CC; Lee JC; Huang WY; Juan CJ; Jen YM; Lin LF
Medicine (Baltimore); 2021 Feb; 100(8):e24555. PubMed ID: 33663063
[TBL] [Abstract][Full Text] [Related]
14. Complete response to radiation therapy for nasopharyngeal sarcomatoid carcinoma.
Lee MJ; Son HJ
J Cancer Res Ther; 2020; 16(3):653-656. PubMed ID: 32719284
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma presenting as bilateral adrenal huge masses.
Doroudinia A; Bakhshayesh Karam M; Ranjbar M; Nikmanesh A; Mehrian P
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29666081
[TBL] [Abstract][Full Text] [Related]
16. In situ mantle cell lymphoma in the nasopharynx.
Koletsa T; Markou K; Ouzounidou S; Tsiompanou F; Karkavelas G; Kostopoulos I
Head Neck; 2013 Nov; 35(11):E333-7. PubMed ID: 23280758
[TBL] [Abstract][Full Text] [Related]
17. [The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
Tang LL; Ma J; Chen Y; Zong JF; Sun Y; Wang Y; Wu HB; Cui NJ
Ai Zheng; 2007 Jul; 26(7):737-41. PubMed ID: 17626750
[TBL] [Abstract][Full Text] [Related]
18. A nodular type of mantle cell lymphoma in the nasopharynx.
Hong YT; Lee H
Ear Nose Throat J; 2021 Dec; ():1455613211062455. PubMed ID: 34913382
[TBL] [Abstract][Full Text] [Related]
19. Preliminary clinical results for PET/MR compared with PET/CT in patients with nasopharyngeal carcinoma.
Cheng Y; Bai L; Shang J; Tang Y; Ling X; Guo B; Gong J; Wang L; Xu H
Oncol Rep; 2020 Jan; 43(1):177-187. PubMed ID: 31746412
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between nasopharyngeal carcinoma and lymphoma at the primary site using whole-tumor histogram analysis of apparent diffusion coefficient maps.
Lian S; Zhang C; Chi J; Huang Y; Shi F; Xie C
Radiol Med; 2020 Jul; 125(7):647-653. PubMed ID: 32072391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
